Glutamic Acid: Clinical Trials

12 trials of Glutamic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 recruiting, 1 terminated. 5 Not applicable, 4 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Unknown 2, Withdrawn 1
Phase 34Completed 3, Recruiting 1
Phase 11Completed 1
Phase 21Terminated 1
Phase 41Completed 1

Follow Glutamic Acid: new trials by email Literature Review of Glutamic Acid trials Research Report on Glutamic Acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
Gamma-aminobutyric acid tartarate, glutamic acid, dibasic calcium phosphate, thiamine nitrate, pyridoxine chloride and cyanocobalamin, Ginger - Vertigo
Phase 4CompletedFundação Educacional Serra dos Órgãos3342021-11-222023-05-17
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
Durvalumab, Carboplatin, Pemetrexed - Non Small Cell Lung Cancer, NSCLC, Stage III
Phase 3RecruitingStanford University482021-08-252026-09-30
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
Bintrafusp Alfa, Pemetrexed, Carboplatin - Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
Phase 2TerminatedM.D. Anderson Cancer Center32021-06-302023-08-01
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
Cellulose (control), Glycine, Alanine - Atherosclerosis, Diet Modification
Not applicableUnknownRambam Health Care Campus1102017-07-012017-06-08
Assessment of Peripheral GABA Receptors for Local Pain Relief
GABA oral solution, Intramuscular GABA, Pain modulation - Pain
Not applicableUnknownAalborg University902016-10-012018-01-10
Glutamate for Metabolic Intervention in Coronary Surgery II
glutamate infusion, saline infusion - Coronary Artery Bypass Surgery, Postoperative Complications
Phase 3CompletedUniversity Hospital, Linkoeping3212015-11-152023-12-04
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Paclitaxel, Carboplatin, Bevacizumab - Lung Cancer
Phase 3CompletedECOG-ACRIN Cancer Research Group15162010-10-252023-07-07
Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition
standard vs. glutamine enteral or parenteral feeding., Stable isotope tracer study, Stable isotope study - Burns
Not applicableWithdrawnMassachusetts General Hospital2009-11-012017-01-13
Anaplerotic Therapy in Propionic Acidemia
ornithine alpha ketoglutarate, glutamine, disodium citrate - Propionic Acidemia
Phase 1CompletedNicola Longo32008-07-012015-01-21
The Influence of Glutamate on Memory in Humans
Sugar pill, Glutamic Acid, Memantine - Healthy Individuals
Not applicableCompletedUniversity Hospital, Bonn1202008-06-012014-12-03
Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study
glutamate and aspartate - Multiple Sclerosis
Not applicableCompletedUniversity Hospital, Caen362007-09-102020-09-02
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
glutamic acid, placebo - Kidney Cancer, Leukemia
Phase 3CompletedUniversity of South Florida2502007-05-012021-08-11

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Lung Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Atherosclerosis (1)  ·  Burkitt Lymphoma (1)  ·  Burning Mouth Syndrome (1)  ·  Burns (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Disease (1)  ·  Facial Pain (1)  ·  Heart Failure (1)  ·  Hyperammonemia (1)  ·  Hyperphagia (1)  ·  Kidney Neoplasms (1)

Sponsors

Aalborg University (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Fundação Educacional Serra dos Órgãos (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Nicola Longo (1)  ·  Rambam Health Care Campus (1)  ·  Stanford University (1)  ·  University Hospital, Bonn (1)  ·  University Hospital, Caen (1)  ·  University Hospital, Linkoeping (1)  ·  University of South Florida (1)

Countries

United States (6)  ·  Brazil (1)  ·  Denmark (1)  ·  Germany (1)  ·  Sweden (1)

Top investigators

Brian E Cairns, PhD DrMed (1)  ·  David R. Freyer, DO, MS (1)  ·  Eric Sandler, MD (1)  ·  Farkas Vanky, MD, PhD (1)  ·  Maximilian Diehn, MD (1)  ·  Nicola Longo, MD, PhD (1)  ·  Rolf Svedjeholm, Professor (1)  ·  Ronald G Tompkins, MD, ScD (1)  ·  Scott Bradfield, MD (1)  ·  Suresh Ramalingam, MD (1)  ·  Tony Hayek, Prof (1)  ·  Xiuning Le (1)

Results publications

PMID 10793599, PMID 12449285, PMID 17364057, PMID 20303474, PMID 24401239, PMID 28712602, PMID 29024230, PMID 31361535, PMID 3537898, PMID 35533197, PMID 37657522, PMID 38252440, PMID 41666849

NIH funding

R21DK077415 (1), U10CA081920 (1)